Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/217838
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorValdor, Ruthes_ES
dc.contributor.authorGarcía-Bernal, Davides_ES
dc.contributor.authorRiquelme, Doloreses_ES
dc.contributor.authorMartínez, Carlos M.es_ES
dc.contributor.authorMoraleda, José Maríaes_ES
dc.contributor.authorCuervo, Ana Mariaes_ES
dc.contributor.authorMacian, Fernandoes_ES
dc.contributor.authorMartínez, Salvadores_ES
dc.date.accessioned2020-08-12T09:57:59Z-
dc.date.available2020-08-12T09:57:59Z-
dc.date.issued2019-
dc.identifier.citationProceedings of the National Academy of Sciences of the USA 116(41): 20655-20665 (2019)es_ES
dc.identifier.issn0027-8424-
dc.identifier.urihttp://hdl.handle.net/10261/217838-
dc.description.abstractThe contractile perivascular cells, pericytes (PC), are hijacked by glioblastoma (GB) to facilitate tumor progression. PC’s protumorigenic function requires direct interaction with tumor cells and contributes to the establishment of immunotolerance to tumor growth. Cancer cells up-regulate their own chaperone-mediated autophagy (CMA), a process that delivers selective cytosolic proteins to lysosomes for degradation, with pro-oncogenic effects. However, the possible impact that cancer cells may have on CMA of surrounding host cells has not been explored. We analyzed the contribution of CMA to the GB-induced changes in PC biology. We have found that CMA is markedly up-regulated in PC in response to the oxidative burst that follows PC–GB cell interaction. Genetic manipulations to block the GB-induced up-regulation of CMA in PC allows them to maintain their proinflammatory function and to support the induction of effective antitumor T cell responses required for GB clearance. GB-induced up-regulation of CMA activity in PC is essential for their effective interaction with GB cells that help tumor growth. We show that CMA inhibition in PC promotes GB cell death and the release of high immunogenic levels of granulocyte-macrophage colony stimulating factor (GM-CSF), through deregulation of the expression of cell-to-cell interaction proteins and protein secretion. A GB mouse model grafted in vivo with CMA-defective PC shows reduced GB proliferation and effective immune response compared to mice grafted with control PC. Our findings identify abnormal up-regulation of CMA as a mechanism by which GB cells elicit the immunosuppressive function of PC and stabilize GB–PC interactions necessary for tumor cell survival.es_ES
dc.description.sponsorshipThis work was funded mainly by Ministerio de Economía y Competitividad de España (MINECO) SAF2015-73923-JIN and Fondo Europeo de Desarrollo Regional/Union Europea (AEI/FEDER/UE) (to R.V.). It was supported partially by Mobility Seneca Foundation Grant “Programa Jimenez de la Espada, 19667/EE/14 (to R.V.); Seneca 20840/PI/18 (to R.V.); ISCIII/Red de Terapia Celular, TERCEL RD16/0011/0010 and RD16/0011/0001 (to S.M. and J.M.M.); and NIH P01 AG031782 (to F.M. and A.M.C.).es_ES
dc.language.isoenges_ES
dc.publisherNational Academy of Sciences (U.S.)es_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2015-73923-JINes_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rightsopenAccesses_ES
dc.subjectChaperone-mediated autophagyes_ES
dc.subjectGlioblastomaes_ES
dc.subjectPericyteses_ES
dc.subjectTumores_ES
dc.subjectImmunosuppressive functiones_ES
dc.titleGlioblastoma ablates pericytes antitumor immune function through aberrant up-regulation of chaperone-mediated autophagyes_ES
dc.typeartículoes_ES
dc.identifier.doi10.1073/pnas.1903542116-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.1073/pnas.1903542116es_ES
dc.identifier.e-issn1091-6490-
dc.rights.licensehttps://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.contributor.funderEuropean Commissiones_ES
dc.contributor.funderFundación Sénecaes_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.relation.csices_ES
oprm.item.hasRevisionno ko 0 false*
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/100007801es_ES
dc.identifier.pmid31548426-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.fulltextWith Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeartículo-
item.cerifentitytypePublications-
item.grantfulltextopen-
Aparece en las colecciones: (IN) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
glioblautophag.pdf2,17 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

47
checked on 25-abr-2024

SCOPUSTM   
Citations

62
checked on 23-abr-2024

WEB OF SCIENCETM
Citations

50
checked on 22-feb-2024

Page view(s)

130
checked on 24-abr-2024

Download(s)

79
checked on 24-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons